Properties
Description
Theliatinib is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells.
Molecular Formula
C25H26N6O2
Identity
Confirmed by NMR/HPLC/MS.
Applications
EGFR-HER2 inhibitor Theliatinib is investigated for its effects on EGFR-HER2 pathways, contributing to cancer research aimed at inhibiting tumor growth.